Collaborate Disseminate
In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, with AstraZeneca revealing “encouraging data” out of its Phase I study of its obesity and diabetes drug AZD5004.Continue ReadingC… Continue reading Weight-loss pill passes important safety trial
A man that police caught taking 217 doses of COVID vaccine has offered himself up to researchers for a study looking into what happens to the immune system after so many doses. The results offer surprising insight into these new mRNA vaccines.Continue … Continue reading What happened to the guy who had 217 COVID vaccinations
Nearly three years after it was first launched, Amazon Web Services’ SageMaker platform has gotten a significant upgrade in the form of new features making it easier for developers to automate and scale each step of the process to build new automation and machine learning capabilities, the company said. As machine learning moves into the […] Continue reading AWS expands on SageMaker capabilities with end-to-end features for machine learning
The attack on eResearchTechnology potentially slowed down coronavirus research worldwide, and researchers suggest a nation-state actor could be behind the incident. Continue reading COVID-19 Clinical Trials Slowed After Ransomware Attack